Blood–tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy

Blood–tumor barrier is a limiting factor for effectiveness of systemic therapy to brain metastases. This study aimed to assess the extent and time course of BTB opening in BM following whole-brain radiotherapy (WBRT) or stereotactic radiosurgery (SRS) to determine optimal timing for systemic therapy.

http://ift.tt/2veMr3n